Overview of available p53 function tests in relation toTP53andATMgene alterations and chemoresistance in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Overview of available p53 function tests in relation toTP53andATMgene alterations and chemoresistance in chronic lymphocytic leukemia

Published:2013-06-24 Issue:8 Volume:54 Page:1849-1853
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

te Raa G. Doreen,Malcikova Jitka,Pospisilova Sarka,Trbusek Martin,Mraz Mark,Garff-Tavernier Maria Le,Merle-Béral Hélène,Lin Ke,Pettitt Andrew R.,Merkel Olaf,Stankovic Tatjana,van Oers Marinus H.,Eldering Eric,Stilgenbauer Stephan,Zenz Thorsten,Kater Arnon P.,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.796058

Reference25 articles.

1. The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemia

2. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia

3. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias

4. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up

5. TP53 Mutation and Survival in Chronic Lymphocytic Leukemia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexistence of diffuse large B-cell lymphoma, acute myeloid leukemia, and untreated lymphoplasmacytic lymphoma/waldenström macroglobulinemia in a same patient: A case report;World Journal of Clinical Cases;2023-06-26

2. Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics;Expert Opinion on Orphan Drugs;2020-08-16

3. Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia;Leukemia;2020-01-27

4. Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing;Molecular Case Studies;2018-04

5. The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability;Cancers;2018-03-05